David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Cytokinetics
CYTK
$10.8B
| $889K | ﹤0.01% |
78,994
-128,245
| -62% | -$1.24M |
|
|
DNR
2702
DELISTED
Denbury Resources, Inc.
DNR
| $889K | ﹤0.01% |
717,438
-1,559,467
| -68% | -$2.83M |
|
|
UFS
2703
DELISTED
DOMTAR CORPORATION (New)
UFS
| $888K | ﹤0.01% |
19,950
-12,966
| -39% | -$592K |
|
2704
CryoPort
CYRX
$847M
| $887K | ﹤0.01% |
48,429
+783
| +2% | +$12.4K |
|
|
JBTM
2705
JBT Marel
JBTM
$6.12B
| $887K | ﹤0.01% |
7,322
-43,354
| -86% | -$4.66M |
|
|
CMA
2706
PUT
DELISTED
Comerica
CMA
| $886K | ﹤0.01% |
+12,200
| New | +$906K |
|
|
ISEE
2707
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $886K | ﹤0.01% |
681,661
-900
| -0.1% | -$1.24K |
|
|
INVX
2708
Innovex International
INVX
$2.01B
| $883K | ﹤0.01% |
18,393
-10,564
| -36% | -$459K |
|
2709
CALL
Nucor
NUE
$56.2B
| $882K | ﹤0.01% |
16,000
-23,500
| -59% | -$1.29M |
|
|
LNW
2710
PUT
DELISTED
Light & Wonder
LNW
| $880K | ﹤0.01% |
44,400
| – | – |
|
2711
The GEO Group
GEO
$4.23B
| $878K | ﹤0.01% |
41,787
-24,113
| -37% | -$509K |
|
|
CYOU
2712
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $876K | ﹤0.01% |
91,133
-90,490
| -50% | -$1.4M |
|
2713
Motorcar Parts of America
MPAA
$222M
| $874K | ﹤0.01% |
+40,821
| New | +$791K |
|
|
SYRS
2714
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $873K | ﹤0.01% |
9,433
-1,836
| -16% | -$128K |
|
|
ZEUS
2715
DELISTED
Olympic Steel
ZEUS
| $870K | ﹤0.01% |
63,708
+14,394
| +29% | +$214K |
|
|
ENZ
2716
DELISTED
Enzo Biochem, Inc.
ENZ
| $869K | ﹤0.01% |
257,796
-36,157
| -12% | -$127K |
|
|
CCXI
2717
DELISTED
ChemoCentryx, Inc.
CCXI
| $867K | ﹤0.01% |
93,210
-33,149
| -26% | -$384K |
|
2718
PUT
Tucows
TCX
$101M
| $866K | ﹤0.01% |
14,200
+1,400
| +11% | +$101K |
|
|
ONIT
2719
Onity Group
ONIT
$294M
| $866K | ﹤0.01% |
27,895
+422
| +2% | +$11.3K |
|
2720
Methode Electronics
MEI
$570M
| $865K | ﹤0.01% |
+30,273
| New | +$848K |
|
2721
Reinsurance Group of America
RGA
$16B
| $865K | ﹤0.01% |
5,547
-2,285
| -29% | -$342K |
|
|
VNE
2722
CALL
DELISTED
Veoneer, Inc.
VNE
| $865K | ﹤0.01% |
+50,000
| New | +$1.05M |
|
2723
J&J Snack Foods
JJSF
$1.67B
| $863K | ﹤0.01% |
5,359
+1,607
| +43% | +$257K |
|
|
HTB
2724
HomeTrust Bancshares
HTB
$771M
| $860K | ﹤0.01% |
34,198
-2,856
| -8% | -$71.8K |
|
2725
PUT
Incyte
INCY
$26.3B
| $858K | ﹤0.01% |
10,100
| – | – |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.